Updates on p53: modulation of p53 degradation as a therapeutic approach

por Dey, A, Verma, C S, Lane, D P
Publicado 2008

P53 abnormalities and outcomes in colorectal cancer: a systematic review

por Munro, A J, Lain, S, Lane, D P
Publicado 2005

Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish

por Chua, J S, Liew, H P, Guo, L, Lane, D P
Publicado 2015

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.

por Vojtĕsek, B., Fisher, C. J., Barnes, D. M., Lane, D. P.
Publicado 1993

Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein

por Menéndez, S, Higgins, M, Berkson, R G, Edling, C, Lane, D P, Laín, S
Publicado 2003

Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane

por Bourdon, J.-C., Renzing, J., Robertson, P.L., Fernandes, K.N., Lane, D.P.
Publicado 2002

Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci

por Frosi, Y., Inoue, K., Ramlan, Siti Radhiah, Lane, D. P., Watanabe, T., Brown, C. J.
Publicado 2019

Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo.

por Hall, P. A., Coates, P. J., Goodlad, R. A., Hart, I. R., lane, D. P.
Publicado 1994

The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage

por Xue, Y, Raharja, A, Sim, W, Wong, E S M, Rahmat, S A B, Lane, D P
Publicado 2017

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

por Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
Publicado 1995

Activation of p53 by scaffold-stabilised expression of Mdm2-binding peptides: visualisation of reporter gene induction at the single-cell level

por Karlsson, G B, Jensen, A, Stevenson, L F, Woods, Y L, Lane, D P, Sørensen, M S
Publicado 2004

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.

por Joypaul, B. V., Hopwood, D., Newman, E. L., Qureshi, S., Grant, A., Ogston, S. A., Lane, D. P., Cuschieri, A.
Publicado 1994

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.

por Wright, C., Mellon, K., Johnston, P., Lane, D. P., Harris, A. L., Horne, C. H., Neal, D. E.
Publicado 1991

Synthetic (10)FN3-based mono- and bivalent inhibitors of MDM2/X function

por Lau, S -Y, Siau, J W, Sobota, R M, Wang, C -I, Zhong, P, Lane, D P, Ghadessy, F J
Publicado 2018

Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery

por Thean, D., Ebo, J. S., Luxton, T., Lee, Xue’Er Cheryl, Yuen, T. Y., Ferrer, F. J., Johannes, C. W., Lane, D. P., Brown, C. J.
Publicado 2017

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.

por Birch, J. M., Heighway, J., Teare, M. D., Kelsey, A. M., Hartley, A. L., Tricker, K. J., Crowther, D., Lane, D. P., Santibáñez-Koref, M. F.
Publicado 1994

Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion

por Muller, P A J, Trinidad, A G, Timpson, P, Morton, J P, Zanivan, S, van den Berghe, P V E, Nixon, C, Karim, S A, Caswell, P T, Noll, J E, Coffill, C R, Lane, D P, Sansom, O J, Neilsen, P M, Norman, J C, Vousden, K H
Publicado 2013